Indoco’s CRO – AnaCipher clears US FDA inspection with ZERO 483
The inspection successfully concluded without any observations and no form 483 is issued
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Hyderabad
US FDA issues six observations to Natco Pharma’s API facility near Hyderabad
The company believes that none of observations are related to data integrity and that all the observations can be addressed within…
Hyderabad lab claims breakthrough in developing Zika vaccine
Bharat Biotech have two candidate vaccines in development. One of them is an inactivated vaccine that has reached the stage of…
TISC’s finalists declared
The finalists were chosen from a total of 100 entries The Indus Entrepreneurs (TiE) Hyderabad, a non-profit organisation focused…
Indian Immunologicals organises workshop
The workshop provided insights into the impact of climate change on infectious disease patterns, in human and animal populations…
Natco Pharma plans five new products for US market
The Rs 850-crore company expects to see organic growth of 15-20 per cent Natco Pharma is preparing to launch about four to five…
Suven posts fourth quarter results
Proposes a dividend of Re 0.60 per share Suven Life Sciences announced its audited financial results for the year ended March 31,…
Novartis India announces next edition of BioCamp
BioCamp will be held in Hyderabad from July 6 to 8, 2015 Novartis Biotechnology Leadership Camp (BioCamp) will be held in…